Edition:
United Kingdom

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

8.80USD
18 May 2018
Change (% chg)

$-0.38 (-4.09%)
Prev Close
$9.18
Open
$9.30
Day's High
$9.30
Day's Low
$8.50
Volume
13,953
Avg. Vol
15,681
52-wk High
$11.90
52-wk Low
$3.90

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.43 December 19 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.71 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.01
Year Ending Dec-19 6 0.05 0.28 0.00 4.16
Earnings (per share)
Quarter Ending Jun-18 6 -0.43 -0.37 -0.47 -0.47
Quarter Ending Sep-18 6 -0.45 -0.39 -0.51 -0.48
Year Ending Dec-18 6 -1.74 -1.46 -1.98 -2.08
Year Ending Dec-19 6 -1.16 -0.26 -1.94 -2.08

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.01
Year Ending Dec-19 0.05 0.06 0.06 3.95 4.16

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings